ArticleTranslational cancer research2025
Exploration of the mechanism of curcumin in the regulation of apoptosis for the treatment of colorectal cancer.
Article in Translational cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The incidence of colorectal cancer (CRC) is steadily increasing, and its standard treatment regimen improves the survival rate of tumor patients, but metastatic CRC is the main cause of death in CRC patients. As a low-toxicity natural compound, curcumin, a traditional Chinese medicine, can effectively inhibit the growth of tumor cells by mediating various biological processes. This study aimed to investigate the molecular mechanism underlying curcumin in the treatment of CRC using a combination of network pharmacology analysis and experimental validation. Methods: The GeneCards database was used to identify potential targets associated with CRC and apoptosis. Target concentrations for curcumin and apoptosis were identified from the Search Tool for Interacting Chemicals (STITCH) and GeneCards databases, respectively. Gene Ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were conducted using the 'clusterprofile' package in R software. Furthermore, to examine the impact of curcumin on the viability and apoptosis of colon cancer cell lines, Cell Counting Kit-8 (CCK-8) assays and flow cytometry analyses were performed. Lastly, Western blot analysis was conducted to validate curcumin's effects on proapoptotic protein. Results: A total of 25 essential genes were identified for protein-protein interaction (PPI) network construction and enrichment analysis. The results of the CCK-8 assay indicated that curcumin exerted inhibitory effects on Conclusions: This study suggests a possible therapeutic approach for CRC by modulating key genes associated with apoptosis, such as MDM2 and COX-2, offering a novel therapeutic strategy for CRC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.